Ian Sacks

Ian Sacks is a declared insider of Healthequity, Inc. (board member), with filings sourced from SEC (Form 4). Between 5 August 2014 and 19 December 2023, the trades on record add up to 29 filings.

On the open market, the record shows 1 purchase worth €523k and 11 sales worth €11.8M. Taken together, the sales exceed the purchases by €11.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants and 3 option exercises. In 2023 alone, the filings show no purchases and 1 sale.

On 21 December 2023 came the latest disclosure, an option exercise for €192k in Healthequity, Inc. The last insider purchase was made public on 7 August 2014, 4,477 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.